KAYZID 250MG INJECTION contains Ceftazidime which belongs to the group of medicines called Antibiotics. It is used to treat urinary tract infections, respiratory infections, skin soft tissue infections, gastrointestinal tract infections and meningitis. It may also be used concomitantly with other antibiotics, such as aminoglycosides, vancomycin, and clindamycin in severe and life-threatening infections and in the immunocompromised patients.
KAYZID 250MG INJECTION do not require dose adjustment in mild to moderate liver disease and safety and efficacy is not established in patients with severe liver disease. Contact your doctor before receiving this medicine.
KAYZID 250MG INJECTION should be used with caution in patients with kidney disease and history of gastrointestinal disease, such as colitis. Contact your doctor before receiving.
KAYZID 250MG INJECTION should be used in pregnancy only if clearly needed as safety of KAYZID 250MG INJECTION in pregnancy is not established. Contact your doctor before receiving.
KAYZID 250MG INJECTION is generally not recommended for use in breastfeeding women as low concentrations may pass through the breast milk do not receive unless considered clearly necessary. Consult your doctor before receiving it.
The safety and efficacy of KAYZID 250MG INJECTION is not established in neonates and infants less than 2 months is not established. Contact your doctor before receiving.
KAYZID 250MG INJECTION should be used with caution in elderly patients especially aged above 80 years of age. Contact your doctor before receiving.
The common side effects are receiving KAYZID 250MG INJECTION are diarrhoea, swelling and redness along a vein, redness, pain, burning, swelling or inflammation at the injection site. Consult your doctor if any of the above side effects worsen.
Used to treat:
Ceftazidime is a bactericidal (works against bacteria) in nature and acts by inhibiting the enzymes which are responsible for formation of cell wall in bacteria.
KAYZID 250MG INJECTION will be given to you as intravenously or intramuscularly only by a doctor or a nurse. Your doctor will administer the correct dose and duration for you depending upon your age, body weight, severity and type of bacterial infection.
Stop receiving KAYZID 250MG INJECTION and contact your physician immediately if you experience any of the following side effects:
Diarrhoea:
Drink plenty of water or fruit juices to keep you hydrated. Don’t take any medicine on your own for treating diarrhoea. Contact your doctor if diarrhoea worsen.
Headache:
Rest and relax. Drink plenty of water and electrolytes. Apply a pain-relieving balm on the head if needed. Do not consume alcohol. Contact your doctor if your headache did not improve.
Dizziness:
Try to rest and relax. Get enough sleep. Avoid driving or operate machinery if you feel dizziness. Avoid alcohol consumption as it aggravates dizziness. Contact your doctor if dizziness worsens.
Itchy skin:
Avoid hot showers because hot water can irritate the skin. Do not scratch the affected area. Use sunscreen and protective clothing when outdoors. Use moisturizers to soothe and hydrate the affected skin area. Contact your doctor if itching worsens.
Nausea or Vomiting:
Take the medicine, with or just after a meal. Stick to simple meals. Avoid eating oily or spicy food. Contact your doctor if nausea and vomiting worsen.
Stomach pain:
Try to rest and relax. Eat small meals but take frequently. Keep a heat pad on your stomach. Contact your doctor if the stomach pain did not improve.
KAYZID 250MG INJECTION should be used in pregnant women only if clearly necessary as safety of KAYZID 250MG INJECTION in pregnancy is not established. Contact your doctor before receiving.
KAYZID 250MG INJECTION is generally not recommended for use in breastfeeding women unless considered clearly necessary as it may pass through the breast milk. Consult your doctor before receiving KAYZID 250MG INJECTION.
KAYZID 250MG INJECTION may cause dizziness which can affect your ability to drive and operate machines. Do not drive or operate any machines if you feel dizzy after receiving KAYZID 250MG INJECTION.
KAYZID 250MG INJECTION should be used with caution in patients with kidney disease. Consult your doctor before receiving KAYZID 250MG INJECTION.
KAYZID 250MG INJECTION should be used with caution hence safety and efficacy is not established in patients with severe liver disease. Contact your doctor before receiving KAYZID 250MG INJECTION.
Do not receive KAYZID 250MG INJECTION if you are allergic to Ceftazidime or other antibiotics such as penicillin, cephalosporin’s, monobactams & carbapenems, or to lignocaine, or to ingredients of the medicine.
Before receiving KAYZID 250MG INJECTION, inform your doctor if you:
Use in pediatrics:
The safety and efficacy of KAYZID 250MG INJECTION has not been established for neonates and infants less than 2 years of age. Your doctor will administer the right dose depends on the child’s age, body weight and severity of the infection.
Use in geriatrics:
KAYZID 250MG INJECTION should be used with caution in elderly patients (especially aged above 80 years of age). Consult your doctor before receiving KAYZID 250MG INJECTION.
A. Drug-Drug interactions:
Before receiving KAYZID 250MG INJECTION, inform your doctor if you are taking any of the following medicine:
Overdosage:
KAYZID 250MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms. Excessive dose of KAYZID 250MG INJECTION in patients suffering from kidney disease may lead to fits, encephalopathy (brain disorder that alters brain functions), asterixis (involuntary movements), neuromuscular excitability, and myoclonia (muscle jerks).
Drug | : | Ceftazidime |
Pharmacological Category | : | Cephalosporin Antibiotics |
Therapeutic Indication | : | Bacterial infections |
Dosage Forms | : | Injection |
What is KAYZID 250MG INJECTION used for?
KAYZID 250MG INJECTION is used to treat urinary tract infections, respiratory infections, skin soft tissue infections, gastrointestinal tract infections and meningitis. It may also be used concomitantly with other antibiotics, such as aminoglycosides, vancomycin, and clindamycin in severe and life-threatening infections and in the immunocompromised patients.
Is KAYZID 250MG INJECTION effective?
KAYZID 250MG INJECTION effective if used in the dose and duration advised by your doctor. Do not stop receiving it even if you see improvement in your condition.
How do you give KAYZID 250MG INJECTION?
KAYZID 250MG INJECTION will be given to you as intravenously or intramuscularly only by a doctor or a nurse Your doctor will administer the correct dose and duration for you depending upon your age, body weight, severity and type of bacterial infection.
Is KAYZID 250MG INJECTION safe for use in patients with liver disorder?
KAYZID 250MG INJECTION should be used with caution hence safety and efficacy is not established in patients with severe liver disease. Contact your doctor before receiving KAYZID 250MG INJECTION.
What are side effects of KAYZID 250MG INJECTION?
The most common side effects of receiving KAYZID 250MG INJECTION are swelling and redness along a vein, pain, burning, swelling or inflammation at the injection site, red raised skin rash, itching, diarrhoea.
1. KD Tripathi. Antimicrobial Drugs. Essentials of pharmacology, 7th edition.2013 page 728.
2. Mayra Matesanz, Jose Mensa. Ceftazidime- Avibactam. Official Journal of Spanish Society of Chemotherapy. September 2021. [Accessed on 13th August 2022]
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683003/
3. CP Pharmaceuticals Ltd. Electronic Medicines Compendium (EMC). [Revised in July 2021] [Accessed on 13th August 2022] https://www.medicines.org.uk/emc/files/pil.6346.pdf
4. ACS DOBFAR Sp. A. Electronic Medicines Compendium (EMC). [Revised in May 2021] [Accessed on 13th August 2022] https://www.medicines.org.uk/emc/files/pil.8751.pdf
5. GlaxoSmithKline. U.S. Food & Drug Administration. [Revised in January 2007] [Accessed on 13th August 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/050578s053,050634s020lbl.pdf
6. GlaxoSmithKline Verona. U.S. Food & Drug Administration. [Revised in July 2017] [Accessed on 13th August 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050578s061,050634s028lbl.pdf
7. Fresenius Kabi Australia Pty Limited. Ceftazidime. [Revised in March 2020] [Accessed on 13th August 2022] https://www.fresenius-kabi.com/au/documents/Ceftazidime_Kabi_PI.pdf
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.